Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study.

Takabayashi, Katsuhiko; Ando, Fumihiko; Ikeda, Kei; Fujita, Shinsuke; Nakajima, Hiroshi; Hanaoka, Hideki; Suzuki, Takahiro

Takabayashi, Katsuhiko; Ando, Fumihiko; Ikeda, Kei; Fujita, Shinsuke; Nakajima, Hiroshi; Hanaoka, Hideki; Suzuki, Takahiro.

Afiliación

Takabayashi K; Department of Internal Medicine, Sanwa Hospital, Chiba, Japan.
Ando F; Division of Medical Informatics and Management, Chiba University Hospital, Chiba, Japan.
Ikeda K; Division of Medical Informatics and Management, Chiba University Hospital, Chiba, Japan.
Fujita S; Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
Nakajima H; Department of Clinical Design and Medicine, Center for Preventive Medical Sciences, Chiba University, Chiba, Japan.
Hanaoka H; Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
Suzuki T; Clinical Research Center, Chiba University Hospital, Chiba, Japan.

Mod Rheumatol ; 32(5): 857-865, 2022 Aug 20.

Article en En | MEDLINE | ID: mdl-34907436

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Antirreumáticos/uso terapéutico; Artritis Reumatoide/tratamiento farmacológico; Artritis Reumatoide/epidemiología; Sustitución de Medicamentos; Humanos; Japón/epidemiología; Estudios Retrospectivos; Resultado del Tratamiento

Palabras clave

JAK inhibitor; bDMARDs; big data; claims data; retention rate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Tipo de estudio: Observational_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google